Viewing Study NCT04235933


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2025-12-27 @ 10:59 PM
Study NCT ID: NCT04235933
Status: COMPLETED
Last Update Posted: 2020-01-22
First Post: 2020-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of TACI-antibody Fusion Protein Injection (RC18) in Healthy Adult Chinese Subjects
Sponsor: RemeGen Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module